Yuting Wu

832 total citations
30 papers, 567 citations indexed

About

Yuting Wu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Yuting Wu has authored 30 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Yuting Wu's work include PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer Mechanisms and Therapy (5 papers). Yuting Wu is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer Mechanisms and Therapy (5 papers). Yuting Wu collaborates with scholars based in China and Hong Kong. Yuting Wu's co-authors include Qingchun Zhao, Xiaochun Qin, Yingshi Zhang, Daiying Zuo, Yingchun Zhou, Honglin Xu, Bin Liu, Guoyong Zhang, Guang‐Hong Chen and Lingpeng Xie and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, ACS Applied Materials & Interfaces and The Journal of Urology.

In The Last Decade

Yuting Wu

29 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuting Wu China 14 351 131 113 104 60 30 567
Ziqi Meng China 16 378 1.1× 149 1.1× 194 1.7× 99 1.0× 48 0.8× 31 635
Jiao Li China 16 392 1.1× 132 1.0× 68 0.6× 107 1.0× 63 1.1× 31 686
Mengyao Sun China 15 414 1.2× 125 1.0× 82 0.7× 97 0.9× 76 1.3× 36 725
Weili Min China 17 299 0.9× 110 0.8× 92 0.8× 132 1.3× 45 0.8× 26 591
Zhirong Jia China 14 316 0.9× 199 1.5× 109 1.0× 89 0.9× 80 1.3× 23 632
Lijing Jiao China 16 298 0.8× 124 0.9× 146 1.3× 185 1.8× 50 0.8× 50 615
Yuhong Sun China 13 238 0.7× 80 0.6× 80 0.7× 124 1.2× 80 1.3× 25 576
Weiwei Shao China 15 424 1.2× 165 1.3× 79 0.7× 112 1.1× 58 1.0× 38 675

Countries citing papers authored by Yuting Wu

Since Specialization
Citations

This map shows the geographic impact of Yuting Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Wu more than expected).

Fields of papers citing papers by Yuting Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuting Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Wu. The network helps show where Yuting Wu may publish in the future.

Co-authorship network of co-authors of Yuting Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuting Wu. A scholar is included among the top collaborators of Yuting Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuting Wu. Yuting Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaomei, et al.. (2025). Ultra-low dose dual-layer detector spectral CT for pulmonary nodule screening: image quality and diagnostic performance. Insights into Imaging. 16(1). 11–11. 2 indexed citations
2.
Wang, Dong, Lei Li, Qian Liu, et al.. (2025). SLC1A5 mediates myocardial damage after myocardial infarction by triggering cardiomyocyte ferroptosis. Biochemical Pharmacology. 239. 117047–117047. 1 indexed citations
3.
Jiang, Bo, Gang Xu, Wei Xia, et al.. (2024). Overexpression of DUSP26 gene suppressed the proliferation, migration, and invasion of human prostate cancer cells. Experimental Cell Research. 442(2). 114231–114231.
4.
Xie, Lingpeng, Guoyong Zhang, Yuting Wu, et al.. (2024). Protective effects of Wenqingyin on sepsis-induced acute lung injury through regulation of the receptor for advanced glycation end products pathway. Phytomedicine. 129. 155654–155654. 8 indexed citations
5.
6.
Wu, Yuting, Guoyong Zhang, Hua Yue, et al.. (2023). Ferrostatin-1 suppresses cardiomyocyte ferroptosis after myocardial infarction by activating Nrf2 signaling. Journal of Pharmacy and Pharmacology. 75(11). 1467–1477. 18 indexed citations
7.
Xu, Honglin, Min Liu, Guang‐Hong Chen, et al.. (2022). Anti-Inflammatory Effects of Ginsenoside Rb3 in LPS-Induced Macrophages Through Direct Inhibition of TLR4 Signaling Pathway. Frontiers in Pharmacology. 13. 714554–714554. 26 indexed citations
8.
Wu, Yuting, Xiangbo Xu, Mingyue Liu, et al.. (2022). DZW-310, a novel phosphoinositide 3-kinase inhibitor, attenuates the angiogenesis and growth of hepatocellular carcinoma cells via PI3K/AKT/mTOR axis. Biochemical Pharmacology. 201. 115093–115093. 8 indexed citations
9.
10.
Zhang, Guoxi, Junrong Zou, Biao Qian, et al.. (2021). Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells. Cell Death and Disease. 12(11). 1067–1067. 7 indexed citations
11.
Lü, Yuan, Xixi Wu, Longshan Zhang, et al.. (2021). SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma. Cancer Immunology Immunotherapy. 71(2). 399–415. 13 indexed citations
12.
Wu, Yuting, Lingpeng Xie, Hua Yue, et al.. (2021). Tanshinone I Inhibits Oxidative Stress–Induced Cardiomyocyte Injury by Modulating Nrf2 Signaling. Frontiers in Pharmacology. 12. 644116–644116. 28 indexed citations
13.
Huang, Weiqiang, Longshan Zhang, Mi Yang, et al.. (2021). Correction to: Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-κB pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 108–108. 1 indexed citations
14.
Chen, Guang‐Hong, Honglin Xu, Yuting Wu, et al.. (2021). Myricetin suppresses the proliferation and migration of vascular smooth muscle cells and inhibits neointimal hyperplasia via suppressing TGFBR1 signaling pathways. Phytomedicine. 92. 153719–153719. 29 indexed citations
15.
Zhang, Guoyong, Guang‐Hong Chen, Yuting Wu, et al.. (2021). Buyang Huanwu Decoction promotes angiogenesis in myocardial infarction through suppression of PTEN and activation of the PI3K/Akt signalling pathway. Journal of Ethnopharmacology. 287. 114929–114929. 29 indexed citations
16.
Wu, Yuting, et al.. (2020). PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharmacological Research. 160. 105195–105195. 102 indexed citations
17.
Zhang, Longshan, Yao Fan, Xiaoqing Wang, et al.. (2020). Carbohydrate Sulfotransferase 4 Inhibits the Progression of Hepatitis B Virus-Related Hepatocellular Carcinoma and Is a Potential Prognostic Marker in Several Tumors. Frontiers in Oncology. 10. 554331–554331. 13 indexed citations
18.
Tan, Zhang‐Bin, Huijie Fan, Yuting Wu, et al.. (2018). Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling. Journal of Ethnopharmacology. 232. 62–72. 14 indexed citations
19.
Xiao, Rihai, Xiaofeng Zou, Xiaoning Wang, et al.. (2012). Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma. Journal of Translational Medicine. 10(1). 200–200. 72 indexed citations
20.
Wu, Gengqing, Xiaoning Wang, Xiaofeng Zou, et al.. (2012). CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma. Medical Oncology. 30(1). 406–406. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziqi Meng Breakdown of academic impact, for papers by Jiao Li Breakdown of academic impact, for papers by Mengyao Sun Breakdown of academic impact, for papers by Weili Min Breakdown of academic impact, for papers by Zhirong Jia Breakdown of academic impact, for papers by Lijing Jiao Breakdown of academic impact, for papers by Yuhong Sun Breakdown of academic impact, for papers by Weiwei Shao
Rankless by CCL
2026